Yew Bio Pharm Cash Flow - Annual (OTCMKTS:YEWB)

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Aug 21, 2017 (Closing)

The Yew Bio Pharm cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the Yew Bio Pharm debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Yew Bio Pharm revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement is essetial while conducting the Yew Bio Pharm cash flow analysis and can be used to measure the operating performance of Yew Bio Pharm compared to various industry peers like CMCI stock and RIBT stock. The cash from operating activities for Yew Bio Pharm is $0.64MĀ for 2016, which saw an increase of -146.72% from previous year. View details of Yew Bio Pharm cash flows for latest & last ten financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec.201620152014201320122011
Yew Bio Pharm Net Income Cash Flow
2M5.28M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization Cash-Flow8.93M7.74M0.68M0.56M0.56M0.47M
Net Increase (Decrease) in Assets Liabilities-12.82M-15.43M-1.35M-0.01M-4.59M-0.15M
Cash From (used in) Discontinued Operations------
Other Adjustments Net2.53M1.03M0.5M-2.24M0.01M
Yew Bio Pharm Net Cash from (used by) Operating Activities
0.64M-1.37M4.11M4.44M0.41M4.37M
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.02M--0.29M-0.31M-0.17M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments------
Other Cash Inflow (Outflow) from Investment Activities0.29M-2.33M-2.44M-3.39M-0.39M-5.51M
Yew Bio Pharm Net Cash from (used by) Invesment Activities
0.23M-2.36M-2.44M-3.69M-0.7M-5.68M
Issuance (Purchase) of Equity Shares------
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings-1.21M3.21M----
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-0.04M0.74M-2.33M--0.06M0.08M
Yew Bio Pharm Net Cash from (used by) Financing Activities
-1.26M3.96M-2.33M--0.06M0.08M
Effect of Exchange Rate Changes on Cash-0.01M-0.03M-0.01M0.02M0.01M0.11M
Yew Bio Pharm Net Change in Cash & Cash Equivalents
-0.4M0.19M-0.67M0.77M-0.34M-1.11M
Cash & Equivalents at Beginning of Year0.68M0.48M1.15M0.38M0.73M1.85M
Cash & Equivalents at Year End0.27M0.68M0.48M1.15M0.38M0.73M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Yew Bio Pharm stock price history and Yew Bio Pharm stock comparison chart inevitably reflect its cash flow situation.
  • Yew Bio Pharm had a Net Change in Cash and Cash Equivalents of $-0.4M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Yew Bio Pharm stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Yew Bio Pharm increased its cash from operating activities to $2.01M in 2016. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $0.64M for YEWB in last year report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-1.26M for Yew Bio Pharm. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin
-0.33